Active Ingredient History
Organization | Org Type | FDA approvals | Clinical Trials involvement | Org ID | Force Sort |
---|
Organization | Org Type | FDA approvals | Clinical Trials involvement | Org ID | Force Sort |
---|
Atherosclerosis (Phase 4)
Constipation (Phase 1/Phase 2)
Diabetes Mellitus (Phase 3)
Diabetes Mellitus, Type 1 (Phase 2)
Diabetes Mellitus, Type 2 (Phase 4)
Endocrine System Diseases (Phase 3)
Glucose Metabolism Disorders (Phase 3)
Healthy Volunteers (Phase 1)
Heart Failure, Diastolic (Phase 3)
Hepatic Insufficiency (Phase 1)
Hypoglycemia (Phase 1)
Kidney Failure, Chronic (Phase 1)
Liver (Phase 1/Phase 2)
Metabolic Diseases (Phase 4)
Metabolism (Phase 3)
Non-alcoholic Fatty Liver Disease (Phase 2)
Obesity (Phase 4)
Obesity, Morbid (Phase 2/Phase 3)
Overweight (Phase 3)
Renal Insufficiency (Phase 1)
Renal Insufficiency, Chronic (Phase 2)
Sleep Apnea Syndromes (Phase 3)
Wolfram Syndrome (Phase 2)
Trial | Phase | Start Date | Organizations | Indications |
---|
Feedback
Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).
Report issue